M33.1

Clinical Causes: The exact cause of other dermatomyositis remains unknown. It is believed to involve an autoimmune response where the immune system mistakenly attacks healthy muscle and skin tissues. Genetic predisposition may play a role, although no specific genes have been conclusively linked. Environmental factors such as certain infections, medications, or exposure to ultraviolet light might contribute to triggering the disease in susceptible individuals. Associations with underlying malignancies have been observed in some adult cases, indicating a possible paraneoplastic phenomenon.

Key Symptoms: Muscle weakness, particularly in the muscles closest to the trunk such as those in the hips, thighs, shoulders, and neck. Skin rashes, often involving the face, neck, shoulders, and chest, exhibiting features like redness, swelling, or a rash resembling a heliotrope (a purple or violet discoloration around the eyes). Gottron’s papules—raised, scaly bumps found over the knuckles, elbows, or knees. Difficulty swallowing or speaking due to throat muscle involvement. Fatigue and general muscle discomfort or tenderness. Sensitivity to sunlight, which can worsen skin symptoms. In some cases, joint pain or swelling may be reported.

Diagnosis Path: Blood tests measuring muscle enzymes like creatine kinase (CK), which are often elevated in muscle inflammation. Antibody tests for specific autoimmune markers associated with dermatomyositis. Electromyography (EMG) to assess electrical activity in muscles and detect inflammation. Muscle biopsy to examine tissue samples for characteristic inflammation and muscle fiber damage. Skin biopsies may also be performed if skin manifestations are prominent. Imaging studies like MRI can identify muscle inflammation and help assess the extent of disease. Screening for underlying malignancies due to the increased risk in adult dermatomyositis patients.

Treatment Protocols: Corticosteroids such as prednisone to reduce inflammation and suppress immune activity. Immunosuppressive drugs like methotrexate, azathioprine, or mycophenolate mofetil to help control the immune response. Physical therapy and gentle exercise to maintain muscle strength and flexibility. Skin management, including the use of sunscreens and topical medications to lessen skin symptoms. Intravenous immunoglobulin (IVIG) in refractory cases resistant to other therapies. Monitoring and screening for associated conditions like malignancies or other autoimmune diseases. Addressing complications such as swallowing difficulties or breathing issues through specialized care.